DocMorris AG (ZRSEF)
90.00
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
DocMorris Shareholders Equity (Quarterly): 512.57M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 512.57M |
| June 30, 2023 | 549.41M |
| June 30, 2023 | 549.41M |
| December 31, 2022 | 378.34M |
| June 30, 2022 | 418.15M |
| June 30, 2022 | 418.15M |
| December 31, 2021 | 530.49M |
| June 30, 2021 | 506.13M |
| June 30, 2021 | 506.13M |
| December 31, 2020 | 608.62M |
| June 30, 2020 | 377.88M |
| Date | Value |
|---|---|
| June 30, 2020 | 377.88M |
| December 31, 2019 | 418.66M |
| June 30, 2019 | 455.94M |
| June 30, 2019 | 455.94M |
| December 31, 2018 | 450.54M |
| June 30, 2018 | 278.21M |
| June 30, 2018 | 278.21M |
| December 31, 2017 | 301.82M |
| June 30, 2017 | 92.46M |
| June 30, 2017 | 92.46M |
| December 31, 2016 | 102.01M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
377.88M
Minimum
Jun 2020
608.62M
Maximum
Dec 2020
470.91M
Average
455.94M
Median
Jun 2019
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 191.25M |
| CRISPR Therapeutics AG | 1.883B |
| Addex Therapeutics Ltd | 1.364M |
| NLS Pharmaceutics Ltd | -4.287M |
| Molecular Partners AG | 210.05M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.032B |
| Total Liabilities (Quarterly) | 518.95M |
| Debt to Equity Ratio | 0.7017 |
| Current Ratio | 1.629 |
| Net Debt Paydown Yield | 5.60% |